Celularity Inc. Form 10-K: Annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-04-30: Form 10-K; Period of report 2025-12-31; Description 10-K; Document form10-k.htm.
- 2025-05-08: Form 10-K; Period of report 2024-12-31; Description Annual report; Document form10-k.htm.
- 2024-07-30: Form 10-K; Period of report 2023-12-31; Description 10-K; Document celu-20231231.htm.
- 2023-03-31: Form 10-K; Period of report 2022-12-31; Description 10-K; Document celu-20221231.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-04-30 | 10-K | 2025-12-31 | 10-K | form10-k.htm |
| 2025-05-08 | 10-K | 2024-12-31 | Annual report | form10-k.htm |
| 2024-07-30 | 10-K | 2023-12-31 | 10-K | celu-20231231.htm |
| 2023-03-31 | 10-K | 2022-12-31 | 10-K | celu-20221231.htm |
| 2022-03-31 | 10-K | 2021-12-31 | 10-K | celu-10k_20211231.htm |
| 2021-03-04 | 10-K | 2020-12-31 | ANNUAL REPORT | f10k2020_gxacquisitioncorp.htm |
| 2020-03-24 | 10-K | 2019-12-31 | ANNUAL REPORT | f10k2019_gxacquisition.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |